Quick Answer
TransMedics Group, Inc. reported Operating Income of $108.58 million for fiscal year 2025.
TransMedics Group, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $108.58M | +189.6% |
| 2024 | $37.50M | +230.5% |
| 2023 | -$28.73M | +8.6% |
| 2022 | -$31.44M | +20.3% |
| 2021 | -$39.43M | -49.4% |
| 2020 | -$26.38M | +10.9% |
| 2019 | -$29.60M | -46.3% |
| 2018 | -$20.24M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $23.30M | +493.9% | -36.3% |
| June 30, 2025 | $36.57M | +192.3% | +33.2% |
| March 31, 2025 | $27.44M | +120.9% | +599.5% |
| September 30, 2024 | $3.92M | +113.8% | -68.6% |
| June 30, 2024 | $12.51M | +1480.6% | +0.7% |
| March 31, 2024 | $12.42M | +694.6% | +143.8% |
| September 30, 2023 | -$28.34M | -411.1% | -3027.5% |
| June 30, 2023 | -$906.0K | +90.7% | +56.6% |
- TransMedics Group, Inc. showed an increase of +189.6% in Operating Income compared to the prior fiscal year.
- Over the 2018–2025 period, TransMedics Group, Inc.’s operating income has grown by 636.6% (from -$20.24 million to $108.58 million).
- The most recent figure is from TransMedics Group, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: